Anti Aging Conference - Preventative Health Care

Dr Mark A Babizhayev PhD
Executive Director of Innovative Vision Products, Inc., Delaware (USA). Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases (RF). Scientific Consultant to Exsymol SAM, Monte Carlo (MC).Executive Director of Innovative Vision Products, Inc., Delaware (USA). Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases (RF). Scientific Consultant to Exsymol SAM, Monte Carlo (MC).

Qualifications:

Graduated from the 2nd Moscow Medical Institute (Pirogov’s), Medico-Biological Faculty as doctor-biophysicist in 1982.
Ph.D. in Biophysics and Pathophysiology at the Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation in 1988.
Recipient Oka Memorial Award, Yokohama, Japan, 1992.
Grantee International Science Foundation in 1994. Place of Residence: Moscow, Russian Federation.

Current Position(s):

Executive Director of Innovative Vision Products, Inc., Delaware (USA).
Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases (RF).
Scientific Consultant to Exsymol SAM, Monte Carlo (MC).

Aspiring professional achievements:

The development of new cosmetic and personal care products, in particular the research documenting the effects of n-acetylcarnosine on senile cataract.

Professional or personal goals in anti-aging/ preventative medicine:

My major interest is in the application of biologically active peptide based compounds and peptidomimetics as novel therapeutical tools, which can be applied for antiageing medicine purposes. My special interest is assigned to the peptide-based antioxidants and their implication for the treatment of age-related disorders, having a component of oxidative stress in their genesis including ophthalmic disorders, (for example cataract, glaucoma and macular degeneration).

2006 - Human Cataracts – the role of Lipid Peroxidation and the efficacy of N-acetylcarnosine as a treatment
Our published studies document an ophthalmic formulation of 1% N-acetylcarnosine, (along with a lubricant- carboxymethylcellulose) can prevent and reverse age-related cataracts in human and in canine eyes. We envisage that this unique eye-drop formula could also provide benefit for:
* Presbyopia.
* Open-angle primary glaucoma.
* Corneal disorders.
* Computer vision syndrome.
* Eyestrain.
* Ocular inflammation.
* Blurred vision.
* Dry eye syndrome.
* Retinal diseases.
* Vitreous opacities and lesions.
* Complications of diabetes mellitus and other systemic diseases.
* Contact lens difficulties, particularly with soft contact lenses.
The interested attendee will learn of these studies and the results of cataract reversal- seen for the very first time by the use of "just" eye-drops.